Skip to Content

Camping World Holdings, Inc.

Company Name Camping World Holdings, Inc.
Stock Symbol CWH
Class Period April 29, 2025 to February 24, 2026
Lead Plaintiff Motion Deadline May 11, 2026

Submit Your Information

If you suffered a loss on your Camping World Holdings, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

Shares Purchased

Number of Shares Buy Date Price Per Share Add

Shares Sold

Number of Shares Sell Date Price Per Share Add

Background

On October 29, 2025, Camping World released its third quarter 2025 financial results, reporting, among other things, a reduction in 2026 guidance to “$310 million on the EBITDA side,” due in part to rebuilding the Company’s “inventory positions.” The Company’s CEO, Marcus Lemonis, further announced he had “laid down the gauntlet with the team” in “pushing them to liquidate out of inventory.”  

On this news, Camping World’s stock fell $4.17, or 24.8%, to close at $12.65 per share on October 29, 2025, thereby injuring investors.

Then, on February 25, 2026, Camping World released its fourth quarter 2025 financial results, reporting, among other things, “a net loss of $(109.1) million” (an increased loss of 83.3%), and “total gross margin was 28.8%, a decrease of 247 basis points.” The Company further disclosed that it “implemented strict, corrective inventory management objectives to structurally improve [] turnover rates. These actions are expected to result in gross margin headwinds in the first half of 2026.”

On this news, Camping World’s stock price fell $1.79, or 16.5%, to close at $9.06 per share on February 25, 2026, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company overstated its ability to “surgically manage [its] inventory” to optimize profit using “data analytics;” (2) the Company overstated the retail demand of consumers it was experiencing and/or reasonably expected; (3) as a result, the Company would require “strict, corrective inventory management objectives,” negatively impacting gross profit and margins; (4) the Company’s inadequate systems and processes prevented it from ensuring reasonably accurate disclosures and/or guidance, including about the health of its balance sheet and/or the ability to manage SG&A expenses; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Submit Your Information